• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

门诊深静脉血栓患者凝血抑制蛋白和纤溶蛋白缺乏情况

Deficiencies of coagulation-inhibiting and fibrinolytic proteins in outpatients with deep-vein thrombosis.

作者信息

Heijboer H, Brandjes D P, Büller H R, Sturk A, ten Cate J W

机构信息

Center for Thrombosis, Haemostasis, and Atherosclerosis Research, Academic Medical Center, Amsterdam, The Netherlands.

出版信息

N Engl J Med. 1990 Nov 29;323(22):1512-6. doi: 10.1056/NEJM199011293232202.

DOI:10.1056/NEJM199011293232202
PMID:2146503
Abstract

BACKGROUND

Isolated deficiencies of antithrombin III, protein C, protein S, and plasminogen have been implicated as a cause of deep-vein thrombosis. It is assumed that patients with recurrent, familial, or juvenile thrombosis are very likely to have such a deficiency.

METHODS

We studied the prevalence of isolated deficiencies of these proteins in 277 consecutive outpatients with venographically proved acute deep-vein thrombosis, as compared with 138 age-matched and sex-matched controls without deep-vein thrombosis, and calculated the positive predictive value of a history of recurrent, familial, or juvenile venous thromboembolism for the presence of such a deficiency.

RESULTS

The overall prevalence of deficiencies of any of these proteins in the patients with venous thrombosis was 8.3 percent (23 of 277 patients) (95 percent confidence interval, 5.4 to 12.4), as compared with 2.2 percent in the controls (3 of 138 subjects) (95 percent confidence interval, 0.5 to 6.1; P less than 0.05 for the comparison between groups). The positive predictive values for the presence of an isolated protein deficiency in patients with recurrent, familial, or juvenile deep-vein thrombosis, defined as the proportion of patients with the clinical finding who had a deficiency of one or more of the proteins, were 9, 16, and 12 percent, respectively.

CONCLUSIONS

The cause of acute venous thrombosis in most outpatients (91.7 percent) cannot be explained by abnormalities of coagulation-inhibiting and fibrinolytic proteins. The information obtained from the medical history concerning recurrent or familial venous thrombosis or the onset of the disease at a young age is not useful for the identification of patients with protein deficiencies.

摘要

背景

抗凝血酶III、蛋白C、蛋白S和纤溶酶原的单独缺乏被认为是深静脉血栓形成的一个原因。据推测,复发性、家族性或青少年血栓形成的患者很可能存在这种缺乏。

方法

我们研究了277例经静脉造影证实为急性深静脉血栓形成的连续门诊患者中这些蛋白单独缺乏的患病率,并与138例年龄和性别匹配且无深静脉血栓形成的对照者进行比较,计算复发性、家族性或青少年静脉血栓栓塞病史对存在这种缺乏的阳性预测值。

结果

静脉血栓形成患者中任何一种这些蛋白缺乏的总体患病率为8.3%(277例患者中有23例)(95%置信区间为5.4%至12.4%),而对照组为2.2%(138例受试者中有3例)(95%置信区间为0.5%至6.1%;两组比较P<0.05)。复发性、家族性或青少年深静脉血栓形成患者中存在单独蛋白缺乏的阳性预测值,定义为有临床发现且一种或多种蛋白缺乏的患者比例,分别为9%、16%和12%。

结论

大多数门诊患者(91.7%)急性静脉血栓形成的原因不能用凝血抑制和纤溶蛋白异常来解释。从病史中获得的有关复发性或家族性静脉血栓形成或年轻时发病的信息,对于识别蛋白缺乏患者并无用处。

相似文献

1
Deficiencies of coagulation-inhibiting and fibrinolytic proteins in outpatients with deep-vein thrombosis.门诊深静脉血栓患者凝血抑制蛋白和纤溶蛋白缺乏情况
N Engl J Med. 1990 Nov 29;323(22):1512-6. doi: 10.1056/NEJM199011293232202.
2
Recurrent venous thrombosis and hypercoagulable states.复发性静脉血栓形成与高凝状态。
Am Fam Physician. 1991 Nov;44(5):1741-51.
3
[Hereditary deficiency of antithrombin III, protein C, protein S and factor XII in 121 patients with venous or arterial thrombosis].121例静脉或动脉血栓形成患者的抗凝血酶III、蛋白C、蛋白S和因子XII遗传性缺乏症
Srp Arh Celok Lek. 1999 Jan-Feb;127(1-2):21-7.
4
[Congenital abnormalities related to coagulation and the fibrinolytic system in patients with vein thrombosis of the lower extremities].[下肢静脉血栓形成患者与凝血及纤维蛋白溶解系统相关的先天性异常]
Nihon Geka Gakkai Zasshi. 1986 Apr;87(4):450-5.
5
[Study of coagulation and fibrinolysis in 131 cases of recurrent deep vein thrombosis].131例复发性深静脉血栓形成患者的凝血与纤溶研究
Nouv Rev Fr Hematol (1978). 1982;24(3):205-9.
6
Involvement of dysplasminogenemia in occurrence of deep vein thrombosis.异常纤溶酶原血症与深静脉血栓形成的关系。
Int Angiol. 1995 Mar;14(1):65-8.
7
The frequency of type I heterozygous protein S and protein C deficiency in 141 unrelated young patients with venous thrombosis.
Thromb Haemost. 1988 Feb 25;59(1):18-22.
8
Hemostatic effects of oral contraceptives in women who developed deep-vein thrombosis while using oral contraceptives.口服避孕药对在使用口服避孕药期间发生深静脉血栓形成的女性的止血作用。
Thromb Haemost. 1998 Sep;80(3):382-7.
9
Hyperhomocysteinemia as a risk factor for deep-vein thrombosis.高同型半胱氨酸血症作为深静脉血栓形成的一个风险因素。
N Engl J Med. 1996 Mar 21;334(12):759-62. doi: 10.1056/NEJM199603213341203.
10
Different incidence of venous thrombosis in patients with inherited deficiencies of antithrombin III, protein C and protein S.抗凝血酶III、蛋白C和蛋白S遗传性缺陷患者静脉血栓形成的发生率不同。
Thromb Haemost. 1994 Jan;71(1):15-8.

引用本文的文献

1
Venous thromboembolism risk in adults with hereditary thrombophilia: a systematic review and meta-analysis.遗传性血栓形成倾向成年人静脉血栓栓塞风险:系统评价和荟萃分析。
Ann Hematol. 2024 Oct;103(10):4285-4294. doi: 10.1007/s00277-024-05926-2. Epub 2024 Aug 21.
2
Risk factors of preoperative deep vein thrombosis in patients with non-traumatic osteonecrosis of the femoral head.非创伤性股骨头坏死患者术前深静脉血栓形成的危险因素。
BMC Musculoskelet Disord. 2024 Jul 30;25(1):602. doi: 10.1186/s12891-024-07736-z.
3
Decreased Thrombin Generation is Associated with Increased Thrombin Generation Biomarkers and Blood Cellular Indices in Pulmonary Embolism.
在肺栓塞中,凝血酶生成减少与凝血酶生成生物标志物和血液细胞指数增加有关。
Clin Appl Thromb Hemost. 2024 Jan-Dec;30:10760296241261076. doi: 10.1177/10760296241261076.
4
Differences in clinical and biological factors between patients with PFO-related stroke and patients with PFO and no cerebral vascular events.与卵圆孔未闭(PFO)相关的中风患者和有卵圆孔未闭但无脑血管事件的患者在临床和生物学因素上的差异。
Front Neurol. 2023 Mar 14;14:1104674. doi: 10.3389/fneur.2023.1104674. eCollection 2023.
5
Prevalence, Genetic Background, and Clinical Phenotype of Congenital Thrombophilia in Chronic Thromboembolic Pulmonary Hypertension.慢性血栓栓塞性肺动脉高压中先天性血栓形成倾向的患病率、遗传背景及临床表型
JACC Asia. 2022 May 17;2(3):247-255. doi: 10.1016/j.jacasi.2022.02.010. eCollection 2022 Jun.
6
Updated recommendations for the treatment of venous thromboembolism.静脉血栓栓塞症治疗的更新建议。
Blood Res. 2021 Mar 31;56(1):6-16. doi: 10.5045/br.2021.2020083.
7
Association between congenital thrombophilia and outcomes in pulmonary embolism patients.先天性血栓形成倾向与肺栓塞患者预后之间的关联。
Blood Adv. 2020 Dec 8;4(23):5958-5965. doi: 10.1182/bloodadvances.2020002955.
8
Association of Thrombophilic Factors in Pathogenesis of Osteonecrosis of Femoral Head in Indian Population.印度人群中血栓形成倾向因素与股骨头坏死发病机制的关联
Indian J Orthop. 2020 Jul 2;54(Suppl 1):33-38. doi: 10.1007/s43465-020-00181-9. eCollection 2020 Sep.
9
Epidemiology, Pathophysiology, and Natural History of Pulmonary Embolism.肺栓塞的流行病学、病理生理学及自然史
Semin Intervent Radiol. 2018 Jun;35(2):92-98. doi: 10.1055/s-0038-1642036. Epub 2018 Jun 4.
10
Latest Innovations in the Treatment of Venous Disease.静脉疾病治疗的最新创新成果。
J Clin Med. 2018 Apr 11;7(4):77. doi: 10.3390/jcm7040077.